Key Takeaways
- Up to 25 percent of active-duty Army members could receive low testosterone results from mandatory screening.
- Medical experts recommend against blanket screenings for these conditions.
- Pentagon has moved forward with the plans despite concerns.
A study published in JAMA has revealed that up to 25 percent of active-duty Army members could receive a low testosterone result from mandatory military screening, according to Defense Secretary Pete Hegseth’s announcement in July.
The findings have raised concerns among medical experts, including the Endocrine Society and the American Urological Association (AUA), who have recommended against such screenings due to the potential for unnecessary medical evaluations, inaccurate results, and overtreatment.
The Pentagon has proceeded with the plans, releasing clinical guidance in September, despite the warnings from medical professionals.
The JAMA study highlights the reasons why testosterone levels are not typically measured in men without symptoms, emphasizing the potential for overdiagnosis and overtreatment in this context.
According to the study, the mandatory screening could lead to a significant number of military members undergoing unnecessary medical evaluations, which could result in infertility and other harmful effects.
Medical experts argue that such screenings should only be conducted in cases where symptoms are present, as the prevalence of low testosterone in the general population is much lower than the screening results suggest.
The Pentagon’s decision to proceed with the mandatory screening has sparked debates about the balance between preventive healthcare and the potential for overdiagnosis and overtreatment.
The study’s findings underscore the need for careful consideration of screening policies and the importance of evidence-based medical practices in the military.
